Zimmer Biomet Receives ‘Concerns’ From FDA
WARSAW — Zimmer Biomet has recently received a Form 483 notice from the FDA. The Form 483 is used by the FDA to document and communicate concerns discovered during routine inspections at the north campus location in Warsaw. The notice was sent to David Kunz, Senior Vice President after … Read More